GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cheng Du Sheng Nuo Biotec Co Ltd (SHSE:688117) » Definitions » Cash Conversion Cycle

Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Cash Conversion Cycle : 261.53 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Cheng Du Sheng Nuo Biotec Co Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Cheng Du Sheng Nuo Biotec Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 63.1.
Cheng Du Sheng Nuo Biotec Co's Days Inventory for the three months ended in Mar. 2025 was 337.24.
Cheng Du Sheng Nuo Biotec Co's Days Payable for the three months ended in Mar. 2025 was 138.81.
Therefore, Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was 261.53.


Cheng Du Sheng Nuo Biotec Co Cash Conversion Cycle Historical Data

The historical data trend for Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cheng Du Sheng Nuo Biotec Co Cash Conversion Cycle Chart

Cheng Du Sheng Nuo Biotec Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial 406.53 367.90 356.62 362.05 376.94

Cheng Du Sheng Nuo Biotec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 414.33 390.60 292.62 359.94 261.53

Competitive Comparison of Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle falls into.


;
;

Cheng Du Sheng Nuo Biotec Co Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=83.79+475.12-181.97
=376.94

Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=63.1+337.24-138.81
=261.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cheng Du Sheng Nuo Biotec Co  (SHSE:688117) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Cheng Du Sheng Nuo Biotec Co Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Cheng Du Sheng Nuo Biotec Co's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Cheng Du Sheng Nuo Biotec Co Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Gongye Avenue, Jinyuan Town, Dayi County, Sichuan Province, Chengdu, CHN, 611330
Cheng Du Sheng Nuo Biotec Co Ltd is a independent research and development, production and sales of peptide raw materials and preparation products.
Executives
Wang Xiao Li Directors, senior managers
Lu Chang Liang senior management
Dong Hua Jian Core technical personnel
Wen Yong Jun Directors, senior managers, core technical personnel
Wu Li Directors, senior managers
Guo De Wen Core technical personnel
Yu Xiao Hai Directors, senior managers
Ma Zhong Gang Senior management, core technical personnel
Zhang Hong Yan Directors, senior managers

Cheng Du Sheng Nuo Biotec Co Headlines

No Headlines